On-line Continuing Education. Course Material: Exam Questions Packet

Size: px
Start display at page:

Download "On-line Continuing Education. Course Material: Exam Questions Packet"

Transcription

1 BREINING INSTITUTE 8894 Greenback Lane Orangevale, California USA Telephone (916) Facsimile (916) On-line Continuing Education Course Material and Exam Questions Packet Course No: CE-1521 Course Title: Best Practices for Substance Abuse Treatment Programs Course Objective: An examination of best practices for substance abuse conditions, adapted from the National Quality Forum s consensus standards, which includes suggested practices for screening and brief intervention; initiation, engagement and re-engagement in treatment; therapeutic interventions to treat substance use conditions; business practices for improved client services; and consideration for individualized care. CE Credit Hours: 3.0 hours Course Material: California s Best System Practices (version 2), by the Department of Alcohol and Drug Programs (ADP) in Reprinted within this packet, and also available on-line through ADP s web site at the following URL: Exam Questions: Eleven (11) multiple-choice questions. Answer Sheet: We recommend that you use the on-line Answer Sheet for automatic grading of your exam, and to automatically receive your Certificate of Completion by . If you mail or fax us the attached Answer Sheet, please allow ten days for us to receive and grade your answers, and to send you the Completion Certificate by postal mail. Recommendation: Review the exam questions before you view the course material. The Exam Questions are based upon the information presented in the course material. You should choose the best answer based upon the information contained within the course material. GOOD LUCK! CE-1521 w Breining Institute ( )

2 BREINING INSTITUTE 8894 Greenback Lane Orangevale, California USA Telephone (916) Facsimile (916) CE-1521: Course Exam Questions These Exam Questions are based upon the information presented in the course material. You should choose the best answer based upon the information contained within the course material. A score of at least 70% correct answers is required to receive Course credit. GOOD LUCK! 1. Initiation, Engagement and Re-Engagement in Treatment consists of all of the following, EXCEPT? a. Diagnosis and assessment. b. Withdrawal management. c. Continuing care management. d. Psychosocial interventions. 2. Therapeutic Interventions to Treat Substance Use Conditions consists of all of the following, EXCEPT? a. Psychosocial interventions. b. Services and support planning. c. Adjunct pharmacotherapy for opioid dependence. d. Adjunct pharmacotherapy for nicotine dependence. 3. Screening entails which of the following? a. Feedback on substance use effects on health (and for alcohol, feedback on use relative to norms), increasing motivation to change, and goal setting. b. Referral for a medical and/or psychological exam for individuals with immediate needs, as determined by qualified personnel. c. Use of a validated screening instrument or interview method for substance use, including quantity, frequency, and pattern. d. Implementation of processes or systems that promote flexibility, immediacy / timeliness, continuity, openness and efficiency. 4. Brief Intervention entails which of the following? a. Feedback on substance use effects on health (and for alcohol, feedback on use relative to norms), increasing motivation to change, and goal setting. b. Referral for a medical and/or psychological exam for individuals with immediate needs, as determined by qualified personnel. c. Use of a validated screening instrument or interview method for substance use, including quantity, frequency, and pattern. d. Implementation of processes or systems that promote flexibility, immediacy / timeliness, continuity, openness and efficiency. CE-1521 w Breining Institute ( )

3 BREINING INSTITUTE 8894 Greenback Lane Orangevale, California USA Telephone (916) Facsimile (916) Diagnosis and Assessment entails which of the following? a. Feedback on substance use effects on health (and for alcohol, feedback on use relative to norms), increasing motivation to change, and goal setting. b. Referral for a medical and/or psychological exam for individuals with immediate needs, as determined by qualified personnel. c. Use of a validated screening instrument or interview method for substance use, including quantity, frequency, and pattern. d. Implementation of processes or systems that promote flexibility, immediacy / timeliness, continuity, openness and efficiency. 6. Engagement in Treatment entails all of the following, EXCEPT: a. Multidimensional assessment that identifies potential barriers to participating in treatment. b. Provision of, or referral to, supportive services. c. Plan developed with client input that is responsive to the individual s culture, language and health literacy. d. Generalized support and reassurance. 7. Services and Supports Planning can be summarized as which of the following? a. Providing information on the efficacy of pharmacotherapy and supported in making an informed choice best suited to the individual client s needs. b. Offering clients long-term, coordinated management of care for their substance use disorder and any co-occurring conditions, which should be adapted based upon ongoing monitoring of the client s progress. c. Empirically validated psychosocial treatment interventions which should be initiated for all persons with substance use problems or dependency. d. Collaboration with clients and their identified support systems to develop a multidimensional services and supports plan that is client-centered, and is periodically re-evaluated to support engagement and progress in treatment. 8. Continuing Care Management can be summarized as which of the following? a. Providing information on the efficacy of pharmacotherapy and supported in making an informed choice best suited to the individual client s needs. b. Offering clients long-term, coordinated management of care for their substance use disorder and any co-occurring conditions, which should be adapted based upon ongoing monitoring of the client s progress. c. Empirically validated psychosocial treatment interventions which should be initiated for all persons with substance use problems or dependency. d. Collaboration with clients and their identified support systems to develop a multidimensional services and supports plan that is client-centered, and is periodically re-evaluated to support engagement and progress in treatment. CE-1521 w Breining Institute ( )

4 BREINING INSTITUTE 8894 Greenback Lane Orangevale, California USA Telephone (916) Facsimile (916) Psychosocial Interventions can be summarized as which of the following? a. Providing information on the efficacy of pharmacotherapy and supported in making an informed choice best suited to the individual client s needs. b. Offering clients long-term, coordinated management of care for their substance use disorder and any co-occurring conditions, which should be adapted based upon ongoing monitoring of the client s progress. c. Empirically validated psychosocial treatment interventions which should be initiated for all persons with substance use problems or dependency. d. Collaboration with clients and their identified support systems to develop a multidimensional services and supports plan that is client-centered, and is periodically re-evaluated to support engagement and progress in treatment. 10. Target outcomes for Adjunct Pharmacotherapy for Opioid Dependence include which of the following? a. Cessation of non-medical use of opioids. b. Retention in treatment. c. Both A and B above. d. Neither A nor B above. 11. For whom should Adjunct Pharmacotherapy for Nicotine Dependence be performed? a. All clients, whether or not there is an indication of nicotine dependence. b. All clients who appear to use nicotine or have nicotine dependence, whether or not they have articulated a desire to quit using nicotine. c. All clients with nicotine dependence, who have a goal of abstinence from nicotine use. d. None of the above. This is an eleven-question examination. Answer Questions 1 through 11 for full CE credit in this course. Questions 12 through 21 have been omitted. CE-1521 w Breining Institute ( )

5 BREINING INSTITUTE 8894 Greenback Lane Orangevale, California USA Telephone (916) Facsimile (916) Course No. CE-1521: Answer Sheet SECTION 1. Please use this sheet only if you have not already submitted your answers on-line. First Name Middle Name Last Name Address (Number, Street, Apt or Suite No.) City State (or Province) USA Zip Code Country (other than USA) Country Code Primary Telephone Number (including Area Code) Facsimile Number (including Area Code) Address SECTION 2. Credit Card Payment information if paying by credit card: Circle which card used - VISA or MasterCard Credit card number Expiration date Full name on credit card. Breining Institute is authorized to charge Twenty-nine dollars ($29.00) to this card. Authorized signature Date SECTION 3. Course Title: CE-1521 / Best Practices for Substance Abuse Treatment Programs Circle correct answer Signature: Date: Return Answer Sheet, with $29 Course examination fee, by mail or facsimile to: BREINING INSTITUTE w 8894 Greenback Lane, Orangevale, California USA w Facsimile (916) CE-1521 w Breining Institute ( )

6 Caal liforrni iaa ss Beesst t Prraacct ticceess forr f Subsst taanccee Ussee Conditionss AAddaappt tteedd ffr froom tthhee t NNaat tti iioonn aal ll QQuuaal lli iit ttyy FFoor ruum ss NNaat tti iioonnaal ll CCoonnsseennssuuss SSt ttaannddaar rddss ffoor f r tthhee t TTr reeaat ttmeennt oof ff SSuubbsst ttaannccee UUssee CCoonnddi iit tti iioonnss Screening and Brief Intervention for Substance Use Conditions Screening During new encounters and anuual check-ups, patients in healthcare settings should be screened for at-risk drinking and substance use problems and dependency, including tobacco use. Brief Intervention All persons identified by screening to be at risk of problems related to substance use should receive a brief motivational counseling intervention by a healthcare provider trained in this technique. Initiation, Engagement and Re-Engagement in Treatment Diagnosis and Assessment Persons with an indication of a substance use problem or illness should be further assessed to confirm that a problem exists and to determine a diagnosis. Persons diagnosed with a substance use disorder should receive a validated multidimensional, biopsychosocial assessment to guide client-centered treatment planning for substance use disorders and any co-occurring conditions. Engagement in Treatment Counties and treatment providers should systematically promote initiation of care and engagement in treatment for substance use disorders. Persons with substance use problems or dependency should receive supportive services to facilitate their participation in ongoing treatment. Withdrawal Management Based on a systematic assessment of the symptoms and risk of serious adverse consequences related to the withdrawal process, support (including pharmacotherapy where indicated) should be provided to manage the symptoms and adverse consequences of withdrawal. Withdrawal management alone does not constitute treatment for dependence and should be linked with ongoing treatment for substance use disorders. Services and Supports Planning Service providers should collaborate with clients and their identified support systems to develop a multidimensional services and supports plan that is client-centered, and is periodically re-evaluated to support engagement and progress in treatment. Continuing Care Management Clients with substance use illness should be offered long-term, coordinated management of care for their substance use disorder and any co-occurring conditions, and this care management should be adapted based on ongoing monitoring of their progress. Therapeutic Interventions to Treat Substance Use Conditions Psychosocial Interventions Empirically validated psychosocial treatment interventions should be initiated for all persons with substance use problems or dependency. Adjunct Pharmacotherapy for Opioid Dependence All clients diagnosed with opioid dependence should be provided with information on the efficacy of pharmacotherapy (e.g. methadone, buprenorphine) and supported in making an informed choice best suited to their needs. Pharmacotherapy, if prescribed, should be provided in addition to and directly linked with psychosocial treatment and support. Adjunct Pharmacotherapy for Alcohol Dependence All clients diagnosed with alcohol dependence should be provided with information on the efficacy of pharmacotherapy (e.g. naltrexone, acamprosate) and supported in making an informed choice best suited to their needs. Pharmacotherapy, if prescribed, should be provided in addition to and directly linked with psychosocial treatment and support. Adjunct Pharmacotherapy for Nicotine Dependence All clients diagnosed with nicotine dependence should be provided with information on the efficacy of pharmacotherapy (e.g. nicotine replacement therapy, bupropion, varenicline) and supported in making an informed choice best suited to their needs. Pharmacotherapy, if prescribed, should be provided in addition to and directly linked with psychosocial treatment and support. Page 1 of 13

7 In Support of Recovery Health Care Family Strengthening Transitional and Supportive Living Crisis Intervention Literacy, Education and Work-Related Supports Nutrition and Exercise Assistance with Legal Issues and Bureaucracy Business Practices For Improved Client Services Coordination of Changes in Levels of Care Clinical Supervision Quality Improvement Staff Development Child Care Tele-health Considerations for Individualized Care Programs should assure that all personnel have an adequate understanding of the individuals they are likely to encounter, and that they provide appropriate supports with empathy and respect, in order to positively influence initiation, engagement and re-engagement (as needed) in treatment. Women / Perinatal Co-Occurring Problems and Disorders Adolescents Elderly Trauma LGBTQ and Gender Minorities Recipients of Public Assistance Programs Criminal Justice Referrals Diverse Cultures Page 2 of 13

8 Screening and Brief Intervention for Substance Use Conditions - DRAFT Screening During new encounters and anuual check-ups, patients in healthcare settings should be screened for at-risk drinking and substance use problems and dependency, including tobacco use. Target Outcome: Identification of persons with alcohol use in excess of NIAAA guidelines for the relevant population, and/or with any illicit drug use, and/or with any tobacco use. Use of a validated screening instrument or interview method for substance use, including quantity, frequency, and pattern (preferably validated in the relevant population). Following a positive screen with a brief intervention and a referral for further assessment if warranted. For Whom It Is Indicated: Persons 10 years of age and older, upon new patient encounters and at least annually thereafter. Any type of healthcare worker with the appropriate training. Where It Should Be Implemented: All appropriate settings (for example, primary, inpatient, urgent, and emergency healthcare; criminal justice healthcare; occupational healthcare; and school-based healthcare settings). Substance use disorder treatment settings should screen for tobacco use. Page 3 of 13

9 Screening and Brief Intervention for Substance Use Conditions - DRAFT Brief Intervention All persons identified by screening to be at risk of problems related to substance use should receive a brief motivational counseling intervention by a healthcare provider trained in this technique. Target Outcome: Cessation or reduction of alcohol and/or illicit drug use and/or tobacco use, and acceptance of treatment when indicated. 5 to 15 minute advice/motivational counseling session. Provided in one to multiple contacts. Includes feedback on substance use effects on health (and for alcohol, feedback on use relative to norms), increasing motivation to change, and goal setting. Multi-contact interventions are more effective and also include further assistance (e.g., recommendations for treatment when indicated) and follow-up monitoring and support. For Whom It Is Indicated: Persons identified with alcohol use in excess of NIAAA guidelines and/or illicit drug use and/or tobacco use. A healthcare provider trained in brief motivational counseling intervention. Any appropriate healthcare setting (for example, primary, inpatient, urgent, and emergency care; criminal justice healthcare; occupational healthcare; and school-based healthcare settings). Specialty treatment settings for substance use disorders should address tobacco use. Page 4 of 13

10 Initiation, Engagement and Re-Engagement in Treatment - DRAFT Diagnosis and Assessment Persons with an indication of a substance use problem or illness should be further assessed to confirm that a problem exists and to determine a diagnosis. Persons diagnosed with a substance use condition should receive a validated multidimensional, biopsychosocial assessment to guide client-centered treatment planning for substance use disorders and any co-occurring conditions. Target Outcomes: Establishment of a diagnosis. Initiation of, or referral for, treatment. Identification of initial and ongoing individualized treatment needs, including co-occurring conditions. Confirmation of a substance use problem or illness. Assessment of all substance use. Use of validated instruments or interview methods (preferably validated in the relevant population). For diagnosed substance use disorders, a multidimensional bio-psycho-social assessment (one that includes, for example, substance use; presence of co-existing general medical and mental health conditions; psychosocial functioning; social factors such as living environment, employment, and support system; and client motivation, preferences, and cultural values as they relate to treatment for substance use illness). Referral for a medical and/or psychological exam for individuals with immediate needs, as determined by qualified personnel. For Whom It Is Indicated: All persons identified through screening or who present with clinical indications or red flags for probable substance use problems or illnesses (for example, a marked change in physical health, deteriorating performance in school or job, dramatic change in personality, involvement in crimes or trauma accidents, needle track marks). Healthcare workers authorized to initiate and guide the treatment of persons with substance use illness. Diagnosis may be performed in general healthcare settings or in county diagnostic facilities. Detailed assessment of treatment needs for substance use illness should be performed in AOD treatment facilities. Page 5 of 13

11 Initiation, Engagement and Re-Engagement in Treatment - DRAFT Engagement in Treatment Counties and treatment providers should systematically promote initiation of care and engagement in treatment for substance use disorders. Persons with substance use problems or dependency should receive supportive services to facilitate their participation in ongoing treatment. Target Outcome: Initiation of treatment after first contact. Continuation of treatment beyond the admission/intake assessment and upon transfer from one level of care to another. Attendance at treatment settings for a sufficient length of time and with an adequate number of sessions per week. Organizational level: Identification of organizational system barriers to the initiation of treatment after first contact/injury/criminal justice diversion and continuation of treatment beyond the admission/intake assessment and upon transfer from one level of care to another. Implementation of processes or systems that promote flexibility, immediacy/timeliness, continuity, openness, and efficiency. Client level: Multidimensional assessment that identifies potential barriers to participating in treatment (for example, living environment, employment, support system, readiness for treatment, coexisting general medical and mental health conditions). Provision of, or referral to, supportive services (for example, housing, legal, employment, child care, medical, or mental health services). Plan developed with client input that is responsive to the individual's culture, language and health literacy. Empathic supportive approach. Active promotion of involvement with community support (some examples include family, 12-step support groups, spiritual support). For Whom It Is Indicated: All persons with substance use problems or dependency. AOD treatment providers and/or certified and licensed counselors authorized to initiate and guide the treatment of persons with substance use disorders. All treatment settings for substance use disorders. Page 6 of 13

12 Initiation, Engagement and Re-Engagement in Treatment - DRAFT Withdrawal Management Based on a systematic assessment of the symptoms and risk of serious adverse consequences related to the withdrawal process, support (including pharmacotherapy where indicated) should be provided to manage the symptoms and adverse consequences of withdrawal. Withdrawal management alone does not constitute treatment for dependence and should be linked with ongoing treatment for substance use disorders. Target Outcome: Control of withdrawal symptoms. Prevention of serious adverse consequences of withdrawal. Engagement in ongoing treatment for substance use dependence. Generalized support and reassurance. Systematic assessment and reassessment of acute withdrawal symptoms and risk of severe symptoms to determine need for medication (e.g., use of a validated instrument). Medications and/or tapering protocols proven to be effective for managing substance use withdrawal, provided in adequate doses to control symptoms and timely adjustments of doses when indicated, with monitoring of response and side effects. Ongoing support and monitoring of medical status including coexisting conditions and medications. Provision of, or referral to, ongoing treatment for dependence. Opioid Withdrawal: Examples of medications proven to be effective for managing opioid withdrawal methadone or buprenorphine tapering. Alcohol withdrawal: Examples of medications proven to be effective for managing alcohol withdrawal benzodiazapenes. For Whom It Should Be Performed: Substance-dependent individuals who desire to withdraw and/or who are in acute phase withdrawal regardless of intent to withdraw (e.g., when incarcerated or hospitalized). Healthcare workers licensed to prescribe medication. Certified counselors who are trained to guide the withdrawal process for substance-dependent individuals. Licensed healthcare personnel who provide medical monitoring and support. AOD detoxification programs. Inpatient or outpatient treatment settings with adequate ongoing medical monitoring capabilities. If dispensing medications, must meet statutory and regulatory requirements at the State and federal levels. Page 7 of 13

13 Initiation, Engagement and Re-Engagement in Treatment - DRAFT Services and Supports Planning Service providers should collaborate with clients and their identified support systems to develop a multidimensional services and supports plan that is client-centered, and is periodically re-evaluated to support engagement and progress in treatment. Target Outcome: A strengths-based plan, informed by assessment and evaluation, that addresses the client s needs and builds upon her/his unique abilities and assets. A working alliance between the client, supportive significant others, and providers of services. Engagement, progress, and retention in treatment. Document assessed needs. Develop reasonably achievable goals in collaboration with the client that address problems identified during assessments. Develop objectives with the client. What action steps will he/she take toward achieving those goals? Identify interventions. What will staff do to assist the client in achieving the desired goal? Identify follow-up times to review the plan. Adjust the plan when ongoing assessments indicate that a more effective intervention is needed, or if there is a change in the need for supportive services. Adjust the plan when goals important to the client have been met or have changed significantly. For Whom It Should be Performed: Every client admitted to treatment for substance use disorders. AOD treatment counselors. AOD treatment settings. Suggested Reference: Treatment Planning M.A.T.R.S Page 8 of 13

14 Initiation, Engagement and Re-Engagement in Treatment - DRAFT Continuing Care Management Clients with substance use illness should be offered long-term, coordinated management of care for their substance use disorder and any co-occurring conditions, and this care management should be adapted based on ongoing monitoring of their progress. Target Outcomes: Client receives care for all conditions that affect recovery. Stabilization of co-occurring conditions. Retention in treatment. Engagement in long-term monitoring. Prevention of relapse or delayed time to relapse. Coordinating administrative, clinical and evaluative activities that bring the client, treatment services, community agencies, and other resources together to focus on issues and needs identified in the assessment(s) and subsequent treatment plan(s), according to the client s preferences. Sharing of diagnostic and treatment information with other service providers, with client s consent. Monitoring the response to treatment and ensuring that when indicated, the treatment plan is modified with client input. Continuing care with an emphasis on providing support and skills for self-management, as for any chronic health condition. Long-term monitoring to identify early signs of relapse. For Whom It Should be Performed: Clients in AOD treatment programs, especially those with co-existing general medical and mental health conditions. Healthcare workers authorized to initiate and/or guide general medical, mental health, or treatment for substance use disorders. Wherever the person is in the care system: Specialty treatment settings when clients are receiving services. General medical and mental healthcare settings when clients are not in specialty treatment. Care management may shift from the specialty setting to the general healthcare setting as clients move into stabilized recovery. Page 9 of 13

15 Therapeutic Interventions to Treat Substance Use Conditions -- DRAFT Psychosocial Interventions Empirically validated psychosocial treatment interventions should be initiated for all persons with substance use problems or dependency. Target Outcome: Cessation or reduction of substance use. Improved psychological and social functioning. Prevention of relapse or delayed time to relapse. Retention in treatment. Varied approaches include motivational enhancement therapy, cognitive behavioral therapies, community reinforcement therapy, 12- step facilitation therapy, structured family and relationship therapies, and contingency management. An empathic, supportive approach may be as important as the specific psychosocial technique. Delivered in various ways, such as individually or in groups, or as brief treatment, as stand-alone treatment or in combination. The manner of delivery is guided by a treatment plan that is responsive to the client s individual needs. Session topics should include problem-solving skills, impulse control, strategies for coping with cravings, development of a supportive environment, and re-assessment and re-evaluation of needs. Involvement with community support is actively promoted. Examples include family (recognized as support by the client), 12-step or other mutual support groups, and spiritual support. For Whom It Should Be Performed: All clients in treatment for substance use disorders. Certified counselors who have been trained in the specific psychosocial intervention and who have appropriate, ongoing supervision. AOD treatment settings. Page 10 of 13

16 Therapeutic Interventions to Treat Substance Use Conditions - DRAFT Adjunct Pharmacotherapy for Opioid Dependence All clients diagnosed with opioid dependence should be provided with information on the efficacy of pharmacotherapy (e.g. methadone, buprenorphine) and supported in making an informed choice best suited to their needs. Pharmacotherapy, if prescribed, should be provided in addition to and directly linked with psychosocial treatment and support. Target Outcome: Cessation of non-medical use of opioids. Retention in treatment. Medications that have been proven to be effective for ongoing treatment of opioid dependence (e.g., methadone, buprenorphine). Provided in adequate doses to control craving. Controlled dispensing of doses. Regular biologic monitoring for illicit drug use. Monitoring of response and side effects. Timely adjustment of doses when indicated. Monitoring of medical status, including co-existing conditions and medications. Provision of empirically validated psychosocial treatment or psychosocial support (including medical management). For Whom It Should be Performed: All adult (and adolescents 16 and older) patients diagnosed with opioid dependence who meet clinical indications and regulatory requirements; may consider for adolescents under 16 as clinically indicated. Special consideration should be given before using pharmacotherapy with selected populations: those with medical contraindications, pregnant or breastfeeding women, adolescents, and the elderly. Healthcare workers licensed and qualified to prescribe medication to treat opioid dependence. Healthcare workers authorized to initiate and guide the treatment of opioid dependent patients should recommend pharmacotherapy. Providers who do not prescribe pharmacotherapy should have formal arrangements to refer patients for pharmacotherapy treatment. Substance use disorder treatment specialty settings. Healthcare settings where patients are treated for substance use illness. If dispensing medications, must meet statutory and regulatory requirements at the State and Federal levels. Page 11 of 13

17 Therapeutic Interventions to Treat Substance Use Conditions - DRAFT Adjunct Pharmacotherapy for Alcohol Dependence All clients diagnosed with alcohol dependence should be provided with information on the efficacy of pharmacotherapy (e.g. naltrexone, acamprosate) and supported in making an informed choice best suited to their needs. Pharmacotherapy, if prescribed, should be provided in addition to and directly linked with psychosocial treatment and support. Target Outcome: Reduction of alcohol consumption with the goal of cessation. Retention in treatment. Medications proven to be effective for treating alcohol dependence (for example, naltrexone, acamprosate). Provided in adequate doses to control craving. Regular monitoring for alcohol use. Monitoring of response and side effects. Timely adjustment of doses when indicated. Monitoring of medical status, including co-existing conditions and medications. Provision of empirically validated psychosocial treatment or psychosocial support (including medical management). For Whom It Should be Performed: All nonpregnant adults (18 and older) that are current alcohol dependent patients. Special consideration should be given before using pharmacotherapy with selected populations: those with medical contraindications, pregnant or breastfeeding women, adolescents, and the elderly. Healthcare workers licensed to prescribe medication. Healthcare workers authorized to initiate and guide the treatment of alcohol dependent patients should offer pharmacotherapy. Providers who do not prescribe pharmacotherapy should have formal arrangements to refer patients for pharmacotherapy treatment. Substance use illness treatment specialty settings. Healthcare settings where patients are treated for substance use illness. If dispensing medications, must meet regulatory requirements at the State and Federal levels. Page 12 of 13

18 Therapeutic Interventions to Treat Substance Use Conditions - DRAFT Adjunct Pharmacotherapy for Nicotine Dependence All clients diagnosed with nicotine dependence should be provided with information on the efficacy of pharmacotherapy (e.g. nicotine replacement therapy, bupropion, varenicline) and supported in making an informed choice best suited to their needs. Pharmacotherapy, if prescribed, should be provided in addition to and directly linked with psychosocial treatment and support. Target Outcome: Cessation of tobacco use. Medications proven to be effective for tobacco cessation (for example, nicotine replacement therapy, bupropion, varenicline). Provided in adequate doses to control craving. Regular monitoring for tobacco use. Monitoring of response and side effects. Timely adjustment of doses when indicated. Monitoring of medical status, including co-existing conditions and medications. Provision of empirically validated psychosocial treatment or psychosocial support. For Whom It Should be Performed: All clients with nicotine dependence, who have a goal of abstinence from nicotine use. Special consideration should be given before using pharmacotherapy with selected populations: those smoking fewer than 10 cigarettes/day, those with medical contraindications, pregnant or breastfeeding women, and adolescents. Healthcare workers licensed to prescribe medication (if prescription required). Healthcare workers authorized to initiate and guide the treatment of substance dependent patients should provide or refer for pharmacotherapy for tobacco cessation. Healthcare workers authorized to initiate and guide general and mental healthcare treatment. Substance use illness treatment specialty settings, general and mental healthcare settings (for example, primary, inpatient, urgent and emergency care; criminal justice healthcare, occupational healthcare, and school-based healthcare settings). If dispensing medications, must meet regulatory requirements at the State and Federal levels. Page 13 of 13

MOVING TOWARD EVIDENCE-BASED PRACTICE FOR ADDICTION TREATMENT

MOVING TOWARD EVIDENCE-BASED PRACTICE FOR ADDICTION TREATMENT MOVING TOWARD EVIDENCE-BASED PRACTICE FOR ADDICTION TREATMENT June, 2014 Dean L. Babcock, LCAC, LCSW Associate Vice President Eskenazi Health Midtown Community Mental Health Centers Why is Evidence-Based

More information

On-line Continuing Education. Course Material: Exam Questions Packet

On-line Continuing Education. Course Material: Exam Questions Packet BREINING INSTITUTE On-line Continuing Education Course Material and Exam Questions Packet Course No: CV-1407 Course Title: Twelve Core Functions and TAP 21 Course Objective: Presentation includes an examination

More information

DrugFacts: Treatment Approaches for Drug Addiction

DrugFacts: Treatment Approaches for Drug Addiction DrugFacts: Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please

More information

Treatment Approaches for Drug Addiction

Treatment Approaches for Drug Addiction Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call 1-800-662-HELP(4357)

More information

MAT Counselor Education Course Exam Questions Packet Part 1

MAT Counselor Education Course Exam Questions Packet Part 1 MAT Counselor Education Course Exam Questions Packet Part 1 Course No: Course Title: Course Objective: MA-1901P1 Medication-Assisted Treatment (MAT) Counselor Education Course Part 1 Includes primer on

More information

American Society of Addiction Medicine

American Society of Addiction Medicine American Society of Addiction Medicine Public Policy Statement on Treatment for Alcohol and Other Drug Addiction 1 I. General Definitions of Addiction Treatment Addiction Treatment is the use of any planned,

More information

Treatment Approaches for Drug Addiction

Treatment Approaches for Drug Addiction Treatment Approaches for Drug Addiction [NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call

More information

Treatment Approaches for Drug Addiction

Treatment Approaches for Drug Addiction Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call the

More information

TREATMENT MODALITIES. May, 2013

TREATMENT MODALITIES. May, 2013 TREATMENT MODALITIES May, 2013 Treatment Modalities New York State Office of Alcoholism and Substance Abuse Services (NYS OASAS) regulates the addiction treatment modalities offered in New York State.

More information

The Federation of State Medical Boards 2013 Model Guidelines for Opioid Addiction Treatment in the Medical Office

The Federation of State Medical Boards 2013 Model Guidelines for Opioid Addiction Treatment in the Medical Office The Federation of State Medical Boards 2013 Model Guidelines for Opioid Addiction Treatment in the Medical Office Adopted April 2013 for Consideration by State Medical Boards 2002 FSMB Model Guidelines

More information

SPECIFICATION FOR THE LOCAL COMMISSIONED SERVICE FOR THE MANAGEMENT ALCOHOL MISUSE

SPECIFICATION FOR THE LOCAL COMMISSIONED SERVICE FOR THE MANAGEMENT ALCOHOL MISUSE SPECIFICATION FOR THE LOCAL COMMISSIONED SERVICE FOR THE MANAGEMENT OF ALCOHOL MISUSE Date: March 2015 1 1. Introduction Alcohol misuse is a major public health problem in Camden with high rates of hospital

More information

National Voluntary Consensus Standards for the Treatment of Substance Use Conditions: Evidence-Based Treatment Practices N ATIONAL Q UALITY F ORUM

National Voluntary Consensus Standards for the Treatment of Substance Use Conditions: Evidence-Based Treatment Practices N ATIONAL Q UALITY F ORUM N ATIONAL Q UALITY F ORUM National Voluntary Consensus Standards for the Treatment of Substance Use Conditions: Evidence-Based Treatment Practices A CONSENSUS REPORT NATIONAL QUALITY FORUM Foreword Excessive

More information

BREINING INSTITUTE 8894 Greenback Lane Orangevale, California USA 95662-4019 Telephone (916) 987-2007 Facsimile (916) 987-8823

BREINING INSTITUTE 8894 Greenback Lane Orangevale, California USA 95662-4019 Telephone (916) 987-2007 Facsimile (916) 987-8823 CV-1403: Course VIDEO Exam Questions These Exam Questions are based upon the information presented in the Course VIDEO. You should choose the best answer based upon the information contained within the

More information

On-line Continuing Education. Course Material: Exam Questions Packet

On-line Continuing Education. Course Material: Exam Questions Packet BREINING INSTITUTE 8894 Greenback Lane Orangevale, California USA 95662-4019 Telephone (916) 987-2007 Facsimile (916) 987-8823 On-line Continuing Education Course Material and Exam Questions Packet Course

More information

Patients are still addicted Buprenorphine is simply a substitute for heroin or

Patients are still addicted Buprenorphine is simply a substitute for heroin or BUPRENORPHINE TREATMENT: A Training For Multidisciplinary Addiction Professionals Module VI: Myths About the Use of Medication in Recovery Patients are still addicted Buprenorphine is simply a substitute

More information

Minnesota Co-occurring Mental Health & Substance Disorders Competencies:

Minnesota Co-occurring Mental Health & Substance Disorders Competencies: Minnesota Co-occurring Mental Health & Substance Disorders Competencies: This document was developed by the Minnesota Department of Human Services over the course of a series of public input meetings held

More information

Evidence Based Approaches to Addiction and Mental Illness Treatment for Adults

Evidence Based Approaches to Addiction and Mental Illness Treatment for Adults Evidence Based Practice Continuum Guidelines The Division of Behavioral Health strongly encourages behavioral health providers in Alaska to implement evidence based practices and effective program models.

More information

UTAH DIVISION OF SUBSTANCE ABUSE AND MENTAL HEALTH SUBSTANCE USE DISORDER SERVICES MONITORING CHECKLIST (FY 2014) GENERAL PROGRAM REQUIREMENTS

UTAH DIVISION OF SUBSTANCE ABUSE AND MENTAL HEALTH SUBSTANCE USE DISORDER SERVICES MONITORING CHECKLIST (FY 2014) GENERAL PROGRAM REQUIREMENTS UTAH DIVISION OF SUBSTANCE ABUSE AND MENTAL HEALTH SUBSTANCE USE DISORDER SERVICES MONITORING CHECKLIST (FY 2014) Program Name Reviewer Name Date(s) of Review GENERAL PROGRAM REQUIREMENTS 2014 Division

More information

Performance Standards

Performance Standards Performance Standards Co-Occurring Disorder Competency Performance Standards are intended to provide a foundation and serve as a tool to promote continuous quality improvement and progression toward best

More information

SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK

SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK National Institute on Drug Abuse SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK U.S. Department of Health and Human National Institutes of Health SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK The goal

More information

4.401 Substance Use Partial Hospitalization Program (Adults and Adolescents)

4.401 Substance Use Partial Hospitalization Program (Adults and Adolescents) 4.40 STRUCTURED DAY TREATMENT SERVICES 4.401 Substance Use Partial Hospitalization Program (Adults and Adolescents) Description of Services: Substance use partial hospitalization is a nonresidential treatment

More information

Many public agencies provide services aimed at preventing, reducing, or

Many public agencies provide services aimed at preventing, reducing, or Publicly-Funded Substance Abuse Services Chapter 3 Developmental Disabilities, and Substance Abuse Services Many public agencies provide services aimed at preventing, reducing, or treating people with

More information

Appendix D. Behavioral Health Partnership. Adolescent/Adult Substance Abuse Guidelines

Appendix D. Behavioral Health Partnership. Adolescent/Adult Substance Abuse Guidelines Appendix D Behavioral Health Partnership Adolescent/Adult Substance Abuse Guidelines Handbook for Providers 92 ASAM CRITERIA The CT BHP utilizes the ASAM PPC-2R criteria for rendering decisions regarding

More information

SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK

SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK National Institute on Drug Abuse SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK U.S. Department of Health and Human National Institutes of Health SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK The goal

More information

Objectives: Perform thorough assessment, and design and implement care plans on 12 or more seriously mentally ill addicted persons.

Objectives: Perform thorough assessment, and design and implement care plans on 12 or more seriously mentally ill addicted persons. Addiction Psychiatry Program Site Specific Goals and Objectives Addiction Psychiatry (ADTU) Goal: By the end of the rotation fellow will acquire the knowledge, skills and attitudes required to recognize

More information

MASSACHUSETTS TOBACCO TREATMENT SPECIALIST TRAINING

MASSACHUSETTS TOBACCO TREATMENT SPECIALIST TRAINING University of Massachusetts Medical School MASSACHUSETTS TOBACCO TREATMENT SPECIALIST TRAINING Course Description Goals and Learning Objectives 1 2012 55 Lake Avenue North, Worcester, MA 01655 www.umassmed.edu/tobacco

More information

Children, youth and families with co-occurring mental health and substance abuse issues are welcomed in every contact, and in every setting.

Children, youth and families with co-occurring mental health and substance abuse issues are welcomed in every contact, and in every setting. Practice Guidelines for the Identification and Treatment of Co-occurring Mental Health and Substance Abuse Issues In Children, Youth and Families June, 2008 This document is adapted from The Vermont Practice

More information

LEVEL III.5 SA: SHORT TERM RESIDENTIAL - Adult (DUAL DIAGNOSIS CAPABLE)

LEVEL III.5 SA: SHORT TERM RESIDENTIAL - Adult (DUAL DIAGNOSIS CAPABLE) LEVEL III.5 SA: SHT TERM RESIDENTIAL - Adult (DUAL DIAGNOSIS CAPABLE) Definition The following is based on the Adult Criteria of the Patient Placement Criteria for the Treatment of Substance-Related Disorders

More information

MEDICAL ASSISTANCE BULLETIN

MEDICAL ASSISTANCE BULLETIN ISSUE DATE September 4, 2015 SUBJECT EFFECTIVE DATE September 9, 2015 MEDICAL ASSISTANCE BULLETIN NUMBER *See below BY Prior Authorization of Opiate Dependence Treatments, Oral Buprenorphine Agents - Pharmacy

More information

Addiction Psychiatry Fellowship Rotation Goals & Objectives

Addiction Psychiatry Fellowship Rotation Goals & Objectives Addiction Psychiatry Fellowship Rotation Goals & Objectives Table of Contents University Neuropsychiatric Institute (UNI) Training Site 2 Inpatient addiction psychiatry rotation.....2 Outpatient addiction

More information

Opioid Treatment Services, Office-Based Opioid Treatment

Opioid Treatment Services, Office-Based Opioid Treatment Optum 1 By United Behavioral Health U.S. Behavioral Health Plan, California Doing Business as OptumHealth Behavioral Solutions of California ( OHBS-CA ) 2015 Level of Care Guidelines Opioid Treatment Services,

More information

Welcome. This presentation is designed for people working in criminal justice and drug abuse treatment settings. It provides an overview of drug

Welcome. This presentation is designed for people working in criminal justice and drug abuse treatment settings. It provides an overview of drug Welcome. This presentation is designed for people working in criminal justice and drug abuse treatment settings. It provides an overview of drug abuse treatment principles for individuals involved in the

More information

CONTINUING EDUCATION (CE) COURSE MATERIAL Course No. CE1204P6 Professional Ethics: AOD Counselor Certification (California)

CONTINUING EDUCATION (CE) COURSE MATERIAL Course No. CE1204P6 Professional Ethics: AOD Counselor Certification (California) CONTINUING EDUCATION (CE) COURSE MATERIAL Course No. CE1204P6 Professional Ethics: AOD Counselor Certification (California) COURSE OBJECTIVE This course will examine the requirements for Alcohol and Other

More information

Evidence Based Practice in the Treatment of Addiction Treatment of Addiction. Steve Hanson

Evidence Based Practice in the Treatment of Addiction Treatment of Addiction. Steve Hanson Evidence Based Practice in the Treatment of Addiction Treatment of Addiction Steve Hanson History of Addiction Treatment Incarceration Medical Techniques Asylums What We Learned These didn t work Needed

More information

Core Competencies for Addiction Medicine, Version 2

Core Competencies for Addiction Medicine, Version 2 Core Competencies for Addiction Medicine, Version 2 Core Competencies, Version 2, was approved by the Directors of the American Board of Addiction Medicine (ABAM) Foundation March 6, 2012 Core Competencies

More information

MEDICAL ASSISTANCE BULLETIN

MEDICAL ASSISTANCE BULLETIN ISSUE DATE SUBJECT EFFECTIVE DATE MEDICAL ASSISTANCE BULLETIN NUMBER *See below BY Prior Authorization of Opiate Dependence Treatments Pharmacy Service Leesa M. Allen, Deputy Secretary Office of Medical

More information

Agency of Human Services

Agency of Human Services Agency of Human Services Practice Guidelines for the Identification and Treatment of Co-occurring Mental Health and Substance Abuse Issues In Children, Youth and Families The Vermont Practice Guidelines

More information

Naltrexone and Alcoholism Treatment Test

Naltrexone and Alcoholism Treatment Test Naltrexone and Alcoholism Treatment Test Following your reading of the course material found in TIP No. 28. Please read the following statements and indicate the correct answer on the answer sheet. A score

More information

BREINING INSTITUTE 8894 GREENBACK LANE ORANGEVALE, CALIFORNIA USA 95662-4019 TELEPHONE (916) 987-2007

BREINING INSTITUTE 8894 GREENBACK LANE ORANGEVALE, CALIFORNIA USA 95662-4019 TELEPHONE (916) 987-2007 BREINING INSTITUTE 8894 GREENBACK LANE ORANGEVALE, CALIFORNIA USA 95662-4019 TELEPHONE (916) 987-2007 Advanced Credential for the Addiction Professional Certified Co-occurring Disorders Specialist (CCDS)

More information

Course Description. SEMESTER I Fundamental Concepts of Substance Abuse MODULE OBJECTIVES

Course Description. SEMESTER I Fundamental Concepts of Substance Abuse MODULE OBJECTIVES Course Description SEMESTER I Fundamental Concepts of Substance Abuse MODULE OBJECTIVES At the end of this course participants will be able to: Define and distinguish between substance use, abuse and dependence

More information

CONTINUING EDUCATION (CE) COURSE MATERIAL Course No. CE1201P1 Prevention and Education: Adolescent Alcohol and Drug Abuse

CONTINUING EDUCATION (CE) COURSE MATERIAL Course No. CE1201P1 Prevention and Education: Adolescent Alcohol and Drug Abuse CONTINUING EDUCATION (CE) COURSE MATERIAL Course No. CE1201P1 Prevention and Education: Adolescent Alcohol and Drug Abuse COURSE OBJECTIVE An examination of the special considerations in the identification,

More information

ANCILLARY STABILIZATION AND WITHDRAWAL. The Why And How Of Stabilizing The Patient In A Comprehensive Treatment Setting

ANCILLARY STABILIZATION AND WITHDRAWAL. The Why And How Of Stabilizing The Patient In A Comprehensive Treatment Setting ANCILLARY STABILIZATION AND WITHDRAWAL The Why And How Of Stabilizing The Patient In A Comprehensive Treatment Setting About CASAColumbia A science-based, multidisciplinary organization Focused on transforming

More information

Program Plan for the Delivery of Treatment Services

Program Plan for the Delivery of Treatment Services Standardized Model for Delivery of Substance Use Services Attachment 5: Nebraska Registered Service Provider s Program Plan for the Delivery of Treatment Services Nebraska Registered Service Provider s

More information

Provider Training. Behavioral Health Screening, Referral, and Coding Requirements

Provider Training. Behavioral Health Screening, Referral, and Coding Requirements Provider Training Behavioral Health Screening, Referral, and Coding Requirements Training Outline I. Behavioral Health Screening Requirements and Referrals II. Healthy Behaviors Substance and Alcohol Abuse

More information

Behavioral Health Provider Implementation of Whole Health Integrative Treatment Services

Behavioral Health Provider Implementation of Whole Health Integrative Treatment Services Behavioral Health Provider Implementation of Whole Health Integrative Treatment Services Maryland Integrative Learning Community Lynn H Albizo, Director of Public Affairs Maryland Addictions Directors

More information

Ambulatory Patient Groups (APG) Policy and Medicaid Billing Guidance OASAS Certified Outpatient Chemical Dependence Programs

Ambulatory Patient Groups (APG) Policy and Medicaid Billing Guidance OASAS Certified Outpatient Chemical Dependence Programs Ambulatory Patient Groups (APG) Policy and Medicaid Billing Guidance OASAS Certified Outpatient Chemical Dependence Programs www.oasas.ny.gov TABLE OF CONTENTS SECTION: PAGE 1. Background and Introduction

More information

Queensland Health Policy

Queensland Health Policy Queensland Health Policy Service delivery for people with dual diagnosis (co-occurring mental health and alcohol and other drug problems) September 2008 Policy statement Individuals experiencing dual diagnosis

More information

NEW HAMPSHIRE CODE OF ADMINISTRATIVE RULES. PART He-W 513 SUBSTANCE USE DISORDER (SUD) TREATMENT AND RECOVERY SUPPORT SERVICES

NEW HAMPSHIRE CODE OF ADMINISTRATIVE RULES. PART He-W 513 SUBSTANCE USE DISORDER (SUD) TREATMENT AND RECOVERY SUPPORT SERVICES CHAPTER He-W 500 MEDICAL ASSISTANCE PART He-W 513 SUBSTANCE USE DISORDER (SUD) TREATMENT AND RECOVERY SUPPORT SERVICES He-W 513.01 Purpose. The purpose of this part is to establish the procedures and requirements

More information

seeking the certification education requirements as an Addiction Counselor through either the

seeking the certification education requirements as an Addiction Counselor through either the 180-Hour Training Series: Addiction Counselor Program The Addiction Certification Program is designed to provide the coursework necessary for those Evidence-Based & Best Practices seeking the certification

More information

New Substance Abuse Screening and Intervention Benefit Covered by BadgerCare Plus and Medicaid

New Substance Abuse Screening and Intervention Benefit Covered by BadgerCare Plus and Medicaid Update December 2009 No. 2009-96 Affected Programs: BadgerCare Plus, Medicaid To: All Providers, HMOs and Other Managed Care Programs New Substance Abuse Screening and Intervention Benefit Covered by BadgerCare

More information

Dartmouth Medical School Curricular Content in Addiction Medicine for Medical Students (DCAMMS) Keyed to LCME Core Competency Domains ***Draft***

Dartmouth Medical School Curricular Content in Addiction Medicine for Medical Students (DCAMMS) Keyed to LCME Core Competency Domains ***Draft*** Dartmouth Medical School Curricular Content in Addiction Medicine for Medical Students (DCAMMS) Keyed to LCME Core Competency Domains ***Draft*** This content, sorted by LCME competencies is intended to

More information

ADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines - 2015

ADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines - 2015 The Clinical Level of Care Guidelines contained on the following pages have been developed as a guide to assist care managers, physicians and providers in making medical necessity decisions about the least

More information

Procedure/ Revenue Code. Billing NPI Required. Rendering NPI Required. Service/Revenue Code Description. Yes No No

Procedure/ Revenue Code. Billing NPI Required. Rendering NPI Required. Service/Revenue Code Description. Yes No No Procedure/ Revenue Code Service/Revenue Code Description Billing NPI Rendering NPI Attending/ Admitting NPI 0100 Inpatient Services Yes No Yes 0114 Room & Board - private psychiatric Yes No Yes 0124 Room

More information

REVISED SUBSTANCE ABUSE GRANTMAKING STRATEGY. The New York Community Trust April 2003

REVISED SUBSTANCE ABUSE GRANTMAKING STRATEGY. The New York Community Trust April 2003 REVISED SUBSTANCE ABUSE GRANTMAKING STRATEGY The New York Community Trust April 2003 1 I. INTRODUCTION Substance Abuse is defined as the excessive use of addictive substances, especially narcotic drugs,

More information

THE OFFICE OF SUBSTANCE ABUSE SERVICES REQUIREMENTS FOR THE PROVISION OF RESIDENTIAL DETOXIFICATION SERVICES BY PROVIDERS FUNDED WITH DBHDS RESOURCES

THE OFFICE OF SUBSTANCE ABUSE SERVICES REQUIREMENTS FOR THE PROVISION OF RESIDENTIAL DETOXIFICATION SERVICES BY PROVIDERS FUNDED WITH DBHDS RESOURCES THE OFFICE OF SUBSTANCE ABUSE SERVICES REQUIREMENTS FOR THE PROVISION OF RESIDENTIAL DETOXIFICATION SERVICES BY PROVIDERS FUNDED WITH DBHDS RESOURCES PURPOSE: The goal of this document is to describe the

More information

Individual Therapies Group Therapies Family Interventions Structural Interventions Contingency Management Housing Interventions Rehabilitation

Individual Therapies Group Therapies Family Interventions Structural Interventions Contingency Management Housing Interventions Rehabilitation 1980s Early studies focused on providing integrated treatment for individuals who have dual diagnosis (adding SA counseling to community MH treatment) Early studies also showed that clients did not readily

More information

BREINING INSTITUTE 8894 GREENBACK LANE ORANGEVALE, CALIFORNIA USA 95662-4019 E-mail CERTIFICATION@BREINING.EDU www.breining.

BREINING INSTITUTE 8894 GREENBACK LANE ORANGEVALE, CALIFORNIA USA 95662-4019 E-mail CERTIFICATION@BREINING.EDU www.breining. BREINING INSTITUTE 8894 GREENBACK LANE ORANGEVALE, CALIFORNIA USA 95662-4019 E-mail CERTIFICATION@BREINING.EDU www.breining.edu Registered Addiction Specialist (RAS) Credential Application The nationally-recognized

More information

Minimum Insurance Benefits for Patients with Opioid Use Disorder The Opioid Use Disorder Epidemic: The Evidence for Opioid Treatment:

Minimum Insurance Benefits for Patients with Opioid Use Disorder The Opioid Use Disorder Epidemic: The Evidence for Opioid Treatment: Minimum Insurance Benefits for Patients with Opioid Use Disorder By David Kan, MD and Tauheed Zaman, MD Adopted by the California Society of Addiction Medicine Committee on Opioids and the California Society

More information

WITH OVER 20 YEARS OF EXPERIENCE, Unity Chemical Dependency is the Rochester area s most experienced and comprehensive treatment provider.

WITH OVER 20 YEARS OF EXPERIENCE, Unity Chemical Dependency is the Rochester area s most experienced and comprehensive treatment provider. WITH OVER 20 YEARS OF EXPERIENCE, Unity Chemical Dependency is the Rochester area s most experienced and comprehensive treatment provider. Our highly trained and dedicated team of counselors and physicians

More information

Goal Statement To administer and manage contracted services to eligible persons in need of health care services to promote health maintenance.

Goal Statement To administer and manage contracted services to eligible persons in need of health care services to promote health maintenance. HEALTH SERVICES To administer and manage contracted services to eligible persons in need of health care services to promote health maintenance. Number of medical encounters provided in the urgent care

More information

Provider enews TREATING PRESCRIPTION DRUG ADDICTION

Provider enews TREATING PRESCRIPTION DRUG ADDICTION Provider enews TREATING PRESCRIPTION DRUG ADDICTION Treating addiction to prescription opioids July 2012 Several options are available for effectively treating prescription opioid addiction. These options

More information

IN THE GENERAL ASSEMBLY STATE OF. Ensuring Access to Medication Assisted Treatment Act

IN THE GENERAL ASSEMBLY STATE OF. Ensuring Access to Medication Assisted Treatment Act IN THE GENERAL ASSEMBLY STATE OF Ensuring Access to Medication Assisted Treatment Act 1 Be it enacted by the People of the State of Assembly:, represented in the General 1 1 1 1 Section 1. Title. This

More information

What is Addiction Treatment?

What is Addiction Treatment? What is Addiction Treatment? During 2000, almost 300,000 people entered addiction treatment services in New York State. On any given day, about 110,000 individuals are enrolled in New York State programs,

More information

STRUCTURED OUTPATIENT ADDICTION PROGRAM (SOAP)

STRUCTURED OUTPATIENT ADDICTION PROGRAM (SOAP) STRUCTURED OUTPATIENT ADDICTION PROGRAM (SOAP) Providers contracted for this level of care or service will be expected to comply with all requirements of these service-specific performance specifications.

More information

DIVISION OF BEHAVIORAL HEALTH SERVICES SUBSTANCE ABUSE TREATMENT SERVICES PLAN

DIVISION OF BEHAVIORAL HEALTH SERVICES SUBSTANCE ABUSE TREATMENT SERVICES PLAN DIVISION OF BEHAVIORAL HEALTH SERVICES SUBSTANCE ABUSE TREATMENT SERVICES PLAN NOVEMBER 2009 SUBSTANCE ABUSE TREATMENT SERVICES PLAN November 2009 Salt Lake County Department of Human Services Division

More information

Quality Management. Substance Abuse Outpatient Care Services Service Delivery Model. Broward County/Fort Lauderdale Eligible Metropolitan Area (EMA)

Quality Management. Substance Abuse Outpatient Care Services Service Delivery Model. Broward County/Fort Lauderdale Eligible Metropolitan Area (EMA) Quality Management Substance Abuse Outpatient Care Services Broward County/Fort Lauderdale Eligible Metropolitan Area (EMA) The creation of this public document is fully funded by a federal Ryan White

More information

Recovery Outcomes for Opiate Users. FRN Research Report November 2013

Recovery Outcomes for Opiate Users. FRN Research Report November 2013 Recovery Outcomes for Opiate Users FRN Research Report November 2013 Introduction Opiate use in America is at epidemic levels. The latest surveys show 4.5 million Americans using prescription painkillers

More information

Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas

Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas David Lakey, MD Commissioner, Department of State Health Services Lauren Lacefield Lewis Assistant Commissioner,

More information

MEDICAL ASSOCIATES HEALTH PLANS HEALTH CARE SERVICES POLICY AND PROCEDURE MANUAL POLICY NUMBER: PP 27

MEDICAL ASSOCIATES HEALTH PLANS HEALTH CARE SERVICES POLICY AND PROCEDURE MANUAL POLICY NUMBER: PP 27 POLICY TITLE: RESIDENTIAL TREATMENT CRITERIA POLICY STATEMENT: Provide consistent criteria when determining coverage for Residential Mental Health and Substance Abuse Treatment. NOTE: This policy applies

More information

VENTURA COUNTY ALCOHOL & DRUG PROGRAMS

VENTURA COUNTY ALCOHOL & DRUG PROGRAMS VENTURA COUNTY ALCOHOL & DRUG PROGRAMS women s services Helping women recover (805) 981-9200 1911 Williams Drive, Oxnard, CA 93036 www.venturacountylimits.org recovery VCBH ALCOHOL & DRUG PROGRAMS WOMEN

More information

Performance Standards

Performance Standards Performance Standards Outpatient Performance Standards are intended to provide a foundation and serve as a tool to promote continuous quality improvement and progression toward best practice performances,

More information

CHAPTER 1223. OUTPATIENT DRUG AND ALCOHOL CLINIC SERVICES

CHAPTER 1223. OUTPATIENT DRUG AND ALCOHOL CLINIC SERVICES CHAPTER 1223. OUTPATIENT DRUG AND ALCOHOL CLINIC SERVICES GENERAL PROVISIONS Sec. 1223.1. Policy. 1223.2. Definitions. 1223.11. Types of services covered. 1223.12. Outpatient services. 1223.13. Inpatient

More information

The concept of National guidelines for treatment of alcohol and drug problems/ dependence in Sweden 2007

The concept of National guidelines for treatment of alcohol and drug problems/ dependence in Sweden 2007 The concept of National guidelines for treatment of alcohol and drug problems/ dependence in Sweden 2007 Ulf Malmström coordinator, PhD National Board of Health and Welfare Cyprus May 2009 Why establish

More information

2015 OPIOID TREATMENT PROGRAM DESCRIPTIONS

2015 OPIOID TREATMENT PROGRAM DESCRIPTIONS 2015 OPIOID TREATMENT PROGRAM PROGRAM DESCRIPTIONS Contents Opioid T reatment Program Core Program Standards... 2 Court Treatment (CT)... 2 Detoxification... 2 Day Treatment... 3 Health Home (HH)... 3

More information

Outline. Drug and Alcohol Counseling 1 Module 1 Basics of Abuse & Addiction

Outline. Drug and Alcohol Counseling 1 Module 1 Basics of Abuse & Addiction Outline Drug and Alcohol Counseling 1 Module 1 Basics of Abuse & Addiction About Substance Abuse The Cost of Chemical Abuse/Addiction Society's Response The Continuum of Chemical Use Definitions of Terms

More information

Clinical Criteria 4.201 Inpatient Medical Withdrawal Management 4.201 Substance Use Inpatient Withdrawal Management (Adults and Adolescents)

Clinical Criteria 4.201 Inpatient Medical Withdrawal Management 4.201 Substance Use Inpatient Withdrawal Management (Adults and Adolescents) 4.201 Inpatient Medical Withdrawal Management 4.201 Substance Use Inpatient Withdrawal Management (Adults and Adolescents) Description of Services: Inpatient withdrawal management is comprised of services

More information

BREINING INSTITUTE 8894 GREENBACK LANE ORANGEVALE, CALIFORNIA USA 95662-4019 E-mail CERTIFICATION@BREINING.EDU www.breining.

BREINING INSTITUTE 8894 GREENBACK LANE ORANGEVALE, CALIFORNIA USA 95662-4019 E-mail CERTIFICATION@BREINING.EDU www.breining. BREINING INSTITUTE 8894 GREENBACK LANE ORANGEVALE, CALIFORNIA USA 95662-4019 E-mail CERTIFICATION@BREINING.EDU www.breining.edu Registered Addiction Specialist (RAS) Credential Application The nationally-recognized

More information

LEVEL I SA: OUTPATIENT INDIVIDUAL THERAPY - Adult

LEVEL I SA: OUTPATIENT INDIVIDUAL THERAPY - Adult LEVEL I SA: OUTPATIENT INDIVIDUAL THERAPY - Adult Definition The following is based on the Adult Criteria of the Patient Placement Criteria for the Treatment of Substance-Related Disorders of the American

More information

FRN Research Report January 2012: Treatment Outcomes for Opiate Addiction at La Paloma

FRN Research Report January 2012: Treatment Outcomes for Opiate Addiction at La Paloma FRN Research Report January 2012: Treatment Outcomes for Opiate Addiction at La Paloma Background A growing opiate abuse epidemic has highlighted the need for effective treatment options. This study documents

More information

Title: Opening Plenary Session Challenges and Opportunities to Impact the Opioid Dependence Crisis

Title: Opening Plenary Session Challenges and Opportunities to Impact the Opioid Dependence Crisis The American Association for the Treatment of Opioid Dependence, provider #1044, is approved as a provider for social work continuing education by the Association of Social Work Boards (ASWB) www.aswb.org,

More information

Presented by. 13 Principles 10/27/09. Principles of Drug Addiction Treatment: A Research Based Guide

Presented by. 13 Principles 10/27/09. Principles of Drug Addiction Treatment: A Research Based Guide Presented by Principles of Drug Addiction Treatment: A Research Based Guide Rick Moldenhauer, MS, LADC, ICADC, LPC Treatment Services Consultant, Alcohol and Drug Abuse Division PO Box 64977, St Paul,

More information

Care Management Council submission date: August 2013. Contact Information

Care Management Council submission date: August 2013. Contact Information Clinical Practice Approval Form Clinical Practice Title: Acute use of Buprenorphine for the Treatment of Opioid Dependence and Detoxification Type of Review: New Clinical Practice Revisions of Existing

More information

Management of Substance Use in the Pregnancy Medical Home Setting Sara McEwen, MD, MPH Executive Director, Governor s Institute

Management of Substance Use in the Pregnancy Medical Home Setting Sara McEwen, MD, MPH Executive Director, Governor s Institute Management of Substance Use in the Pregnancy Medical Home Setting Sara McEwen, MD, MPH Executive Director, Governor s Institute 1 Webinar Objectives Describe SBIRT approach to manage substance use in pregnancy

More information

Outpatient and Intensive Outpatient Narrative

Outpatient and Intensive Outpatient Narrative Los Angeles County Department of Public Health Substance Abuse Prevention and Control (SAPC) will implement an initial benefit package of Substance Use Disorder (SUD) services within the initial twelve

More information

Department of Mental Health and Addiction Services 17a-453a-1 2

Department of Mental Health and Addiction Services 17a-453a-1 2 17a-453a-1 2 DEPARTMENT OF MENTAL HEALTH AND ADDICTION SERVICES General Assistance Behavioral Health Program The Regulations of Connecticut State Agencies are amended by adding sections 17a-453a-1 to 17a-453a-19,

More information

Delivery of Tobacco Dependence Treatment for Tobacco Users with Mental Illness and Substance Use Disorders (MISUD)

Delivery of Tobacco Dependence Treatment for Tobacco Users with Mental Illness and Substance Use Disorders (MISUD) Delivery of Tobacco Dependence Treatment for Tobacco Users with Mental Illness and Substance Use Disorders (MISUD) Learning Objectives Upon completion of this module, you should be able to: Describe how

More information

3.1 TWELVE CORE FUNCTIONS OF THE CERTIFIED COUNSELLOR

3.1 TWELVE CORE FUNCTIONS OF THE CERTIFIED COUNSELLOR 3.1 TWELVE CORE FUNCTIONS OF THE CERTIFIED COUNSELLOR The Case Presentation Method is based on the Twelve Core Functions. Scores on the CPM are based on the for each core function. The counsellor must

More information

National Survey of Substance Abuse Treatment Services (N-SSATS)

National Survey of Substance Abuse Treatment Services (N-SSATS) U.S. Department of Health and Human Services FORM APPROVED: OMB No. 0930-0106 APPROVAL EXPIRES: 01/31/2016 See OMB burden statement on last page National Survey of Substance Abuse Treatment Services (N-SSATS)

More information

Developing Medications to Treat Addiction: Implications for Policy and Practice. Nora D. Volkow, M.D. Director National Institute on Drug Abuse

Developing Medications to Treat Addiction: Implications for Policy and Practice. Nora D. Volkow, M.D. Director National Institute on Drug Abuse Developing Medications to Treat Addiction: Implications for Policy and Practice Nora D. Volkow, M.D. Director National Institute on Drug Abuse Medications Currently Available For Nicotine Addiction Nicotine

More information

Triage, Assessment & Treatment Methadone 101/Hospitalist Workshop

Triage, Assessment & Treatment Methadone 101/Hospitalist Workshop Triage, Assessment & Treatment Methadone 101/Hospitalist Workshop Launette Rieb, MSc, MD, CCFP, FCFP Clinical Associate Professor, Dept. Family Practice UBC American Board of Addiction Medicine Certified

More information

OUTPATIENT SERVICES. Components of Service

OUTPATIENT SERVICES. Components of Service OUTPATIENT SERVICES Providers contracted for this level of care or service are expected to comply with all requirements of these service-specific performance specifications. Additionally, providers contracted

More information

INSTRUCTIONS AND PROTOCOLS FOR THE IMPLEMENTATION OF CASE MANAGEMENT SERVICES FOR INDIVIDUALS AND FAMILIES WITH SUBSTANCE USE DISORDERS

INSTRUCTIONS AND PROTOCOLS FOR THE IMPLEMENTATION OF CASE MANAGEMENT SERVICES FOR INDIVIDUALS AND FAMILIES WITH SUBSTANCE USE DISORDERS 201 Mulholland Bay City, MI 48708 P 989-497-1344 F 989-497-1348 www.riverhaven-ca.org Title: Case Management Protocol Original Date: March 30, 2009 Latest Revision Date: August 6, 2013 Approval/Release

More information

Free Additional Resources

Free Additional Resources Free Additional Resources Substance Abuse and Mental Health Services Administration Treatment Improvement Protocols The Substance Abuse and Mental Health Services Administration (SAMHSA) offers free Treatment

More information

Guidelines for the Use of Controlled Substances in the Treatment of Pain Adopted by the New Hampshire Medical Society, July 1998

Guidelines for the Use of Controlled Substances in the Treatment of Pain Adopted by the New Hampshire Medical Society, July 1998 Guidelines for the Use of Controlled Substances in the Treatment of Pain Adopted by the New Hampshire Medical Society, July 1998 Section I: Preamble The New Hampshire Medical Society believes that principles

More information

2011 State Profile California

2011 State Profile California 20 State Profile California National Survey of Substance Abuse Treatment Services (N-SSATS) The National Survey of Substance Abuse Treatment Services (N-SSATS) is an annual survey of facilities providing

More information

Prescriber Behavior, Pain Treatment and Addiction Treatment

Prescriber Behavior, Pain Treatment and Addiction Treatment Prescriber Behavior, Pain Treatment and Addiction Treatment Mary Fleming, M.S. Director, Office of Policy, Planning, and Innovation Substance Abuse and Mental Health Services Administration NGA Policy

More information

Maintenance of abstinence in alcohol dependence

Maintenance of abstinence in alcohol dependence Shared Care Guideline for Prescription and monitoring of Acamprosate Calcium Author(s)/Originator(s): (please state author name and department) Dr Daly - Consultant Psychiatrist, Alcohol Services Dr Donnelly

More information

Substance Use Disorder Screening and Testing 35-45-3

Substance Use Disorder Screening and Testing 35-45-3 Policy The Department of Children and Families shall screen all adult and adolescent clients for indicators of substance use disorders and refer those in need of further assessment or treatment to an appropriate

More information

Transitional Grant Area (TGA) Definition

Transitional Grant Area (TGA) Definition S OF CARE Oakland Transitional Grant Area Care and Treatment Services O CTOBER 2006 Office of AIDS Administration 1000 Broadway, Suite 310 Oakland, CA 94607 Tel: 510.268.7630 Fax: 510.268.7631 AREAS OF

More information

ACUTE TREATMENT SERVICES (ATS) FOR SUBSTANCE USE DISORDERS LEVEL III.7

ACUTE TREATMENT SERVICES (ATS) FOR SUBSTANCE USE DISORDERS LEVEL III.7 ACUTE TREATMENT SERVICES (ATS) FOR SUBSTANCE USE DISORDERS LEVEL III.7 Providers contracted for this level of care or service are expected to comply with all requirements of these service-specific performance

More information